Farallon Capital Management LLC Portfolio Holdings

Farallon Capital Management LLC

  • $17.4 Billion
  • Q1 2025

Farallon Capital Management LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $17.4 Billion distributed in 135 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $858M, Exelixis, Inc. with a value of $832M, Unitedhealth Group Inc with a value of $785M, Natera, Inc. with a value of $643M, and Iqvia Holdings Inc. with a value of $602M.

Examining the 13F form we can see an decrease of $316B in the current position value, from $333B to 17.4B. Also it can be appreciated an additional of 16 stocks purchases and 4 closed positions.

Farallon Capital Management LLC is based out at San Francisco, CA

Below you can find more details about Farallon Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $17.4 Billion
Healthcare: $7.3 Billion
Technology: $2.78 Billion
ETFs: $2.31 Billion
Industrials: $1.56 Billion
Financial Services: $1.48 Billion
Communication Services: $1.28 Billion
Real Estate: $327 Million
Consumer Defensive: $297 Million
Other: $76.4 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.3B
$20 Million 0.11% of portfolio
2,439,120
Q1 2025 Added 275.25%
$150M
$11.7 Million 0.07% of portfolio
2,122,262
Q1 2025 Added 0.66%
$3.68B
$10.6 Million 0.06% of portfolio
150,000
Q3 2024 New
$456M
$10.6 Million 0.06% of portfolio
1,143,818
Q1 2025 Added 14.27%
$124M
$8.69 Million 0.05% of portfolio
2,570,700
Q4 2024 Added 12.16%
$604M
$6.32 Million 0.04% of portfolio
4,610,930
Q1 2025 Added 15.27%
$4.43B
$6.08 Million 0.03% of portfolio
83,000
Q1 2025 Added 2,205.56%
$204M
$4.42 Million 0.03% of portfolio
175,000
Q1 2025 New
$2.93B
$5.21 Million 0.03% of portfolio
118,000
Q1 2025 New
$1.11B
$2.94 Million 0.02% of portfolio
150,000
Q4 2023 New
$656M
$4.17 Million 0.02% of portfolio
912,000
Q1 2025 New
$5.96B
$1.1 Million 0.01% of portfolio
3,319
Q4 2023 New
$2.42B
$1.48 Million 0.01% of portfolio
29,298
Q1 2025 Reduced 92.94%
$232M
$1.49 Million 0.01% of portfolio
750,000
Q1 2024 New
$12.4M
$1.17 Million 0.01% of portfolio
1,859,308
Q1 2025 Reduced 51.22%
$2.28B
$1.45 Million 0.01% of portfolio
37,000
Q1 2025 New
$1.16B
$1.3 Million 0.01% of portfolio
48,000
Q4 2024 New
$716M
$112,000 0.0% of portfolio
23,000
Q1 2024 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 94.44%
$2.21B
$225,000 0.0% of portfolio
7,000
Q4 2024 New
Beta Bionics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
$8.21B
$373,000 0.0% of portfolio
37,000
Q3 2024 Reduced 94.5%
$4.81B
$466,000 0.0% of portfolio
4,000
Q4 2023 New
$23.5B
$249,000 0.0% of portfolio
1,100
Q3 2024 New
$2B
$201,000 0.0% of portfolio
15,800
Q1 2025 Reduced 97.49%
Revolution Medicines Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
$543M
$340,000 0.0% of portfolio
42,800
Q4 2023 New
$4.18B
$244,000 0.0% of portfolio
14,000
Q4 2023 New
Aleanna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Waystar Hldg Corp
-
$0 0.0% of portfolio
-
Q1 2025 Added 50.52%
Aleanna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
$199M
$138,000 0.0% of portfolio
27,600
Q2 2024 Reduced 94.13%
$1.76B
$130,000 0.0% of portfolio
16,000
Q4 2023 New
$13.5B
$308,000 0.0% of portfolio
1,000
Q3 2024 Reduced 99.3%
$710M
$148,000 0.0% of portfolio
14,000
Q1 2025 New
$2.02B
$300,000 0.0% of portfolio
7,650
Q4 2024 Reduced 97.75%
$2.94B
$262,000 0.0% of portfolio
4,000
Q4 2023 New
$3.58B
$201,000 0.0% of portfolio
3,000
Q1 2025 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 19.63%
$547M
$122,000 0.0% of portfolio
10,000
Q4 2023 New
Summit Midstream Corporation
-
$0 0.0% of portfolio
-
Q3 2024 New
$932M
$406,000 0.0% of portfolio
26,000
Q2 2024 Reduced 98.54%
$0
$68,000 0.0% of portfolio
405,316
Q4 2023 New
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 69.92%
Beyond Meat Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
$2.12B
$402,000 0.0% of portfolio
18,000
Q4 2024 Reduced 98.07%
$6.82B
$246,000 0.0% of portfolio
400
Q4 2023 New
$369M
$86,000 0.0% of portfolio
26,000
Q1 2024 Reduced 95.37%
$802M
$101,000 0.0% of portfolio
17,000
Q3 2024 Reduced 96.0%

Summary

  • Portfolio
  • No. of Stocks 135
  • Current Value $17.4 Billion
  • Prior Value $333 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 16 stocks
  • Additional Purchases 40 stocks
  • Sold out of 4 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email